Impact that’s exponential.
The RegaloRx unique model and business structure is tackling two important issues with one solution:
Millions of patients in the U.S. cannot afford the most innovative, life changing medications, including those who are uninsured or under-insured, and elderly patients with limited fixed incomes. RegaloRx is helping pharmaceutical companies fill this access gap with efficient, reliable patient assistance program services.
Heart to Heart International delivers essential healthcare and medications to millions of vulnerable people around the world. Funding from RegaloRx adds to the positive impact that many pharmaceutical companies already have by working with Heart to Heart International.
It’s a unique combination of purpose and profits that makes a difference in the lives of patients and providers today and an exponential positive impact for the future.
Making a difference for patients today.
“We love hearing good calls. The patient called and provided feedback on the program, spoke highly of your agent and commented on the wonderful customer service! They were not calling for a refill, or any other questions - simply to relay good feedback. It’s completely unsolicited and speaks volumes about the work you do!” - RegaloRx Client
Creating global impact for the future.
Heart to Heart International works to improve healthcare access in the U.S. and around the world by ensuring quality care is provided equitably in medically under-resourced communities and in disaster situations.
Since 1992, the nonprofit organization has shipped medical products and provided services in 131 countries around the world, totaling more than $2.4 billion in aid. More than 1.1 million volunteer hours have helped make this happen.
Heart to Heart International is a founding member of the Partnership for Quality Medical Donations (PQMD), a collaborative organization bringing the medical industry and humanitarian groups together to meet critical needs.